Chargement en cours...
Predictive value of the SLC22A18 protein expression in glioblastoma patients receiving temozolomide therapy
BACKGROUND: Our previous study showed that SLC22A18 downregulation and promoter methylation were associated with the development and progression of glioma and the elevated expression of SLC22A18 was found to increase the sensitivity of glioma U251 cells to the anticancer drug 1,3-bis(2-chloroethyl)-...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3610152/ https://ncbi.nlm.nih.gov/pubmed/23514245 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-11-69 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|